DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
Breaking News
DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
By BOB CLARK bclark@oleantimesherald.com 
August 29, 2025
FRANKLINVILLE — State environmental officers said immediate changes are needed after a fish kill in Ischua Creek was triggered by pollution from the G...
Home Online Features FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
Hand-out
Press Releases
LEADS BIOLABS  
November 22, 2024

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

NANJING, China, Nov. 22, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social